Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Blocking IL-17a can improve age-related smell loss in mice.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Psoriatic alopecia is a challenging hair loss condition linked to psoriasis, needing better diagnosis and personalized treatments.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.